ENDOMETRIAL

Clinical trials for ENDOMETRIAL explained in plain language.

Never miss a new study

Get alerted when new ENDOMETRIAL trials appear

Sign up with your email to follow new studies for ENDOMETRIAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug cocktail targets Hard-to-Treat endometrial cancer

Disease control Not yet recruiting

This early-phase study tests a combination of three drugs (avutometinib, defactinib, and everolimus) in people with recurrent endometrial cancer that has specific RAS gene changes. The main goal is to find the safest dose and understand side effects. About 31 participants will ta…

Matched conditions: ENDOMETRIAL

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 29, 2026 02:24 UTC

ENDOMETRIAL

Get alerted when new ENDOMETRIAL trials appear

New drug cocktail targets Hard-to-Treat endometrial cancer